CEOs of Priavoid

CEOs of Priavoid

CEOs of Priavoid 21st February 2019: Dr. Antje Willuweit and Dr. Sabine Willbold became CEOs of Priavoid. News & Events: AAIC 2019 Keystone Symposium Neuro4D Conference Seed Investment CEOs of Priavoid AD/PD 2019 – Lisbon BioRiver Boost! 2018 The Nobel Prize...
Prof. Willbold´s interview with PharmaVentures

Prof. Willbold´s interview with PharmaVentures

Prof. Willbold´s interview with PharmaVentures November 14th, 2017 Learn more Prof. Dieter Willbold talks with Summer Park of PharmaVentures at Biotech and Money Investival, London in 2017. News & Events: AAIC 2019 Keystone Symposium Neuro4D Conference Seed...
Science September 7th, 2017

Science September 7th, 2017

Science | AAAS September 7th, 2017 Learn more Recent research on the fibril structure of amyloid-ß(1-42) by cryo-electron microscopy is presented by Gremer et al. in Science, Vol. 358   Press Release News & Events: AAIC 2019 Keystone Symposium Neuro4D...
Clinical trial with PRI-002

Clinical trial with PRI-002

Clinical trial with PRI-002 Learn More PRI-002 completed the MAD part of the phase I study up to 320mg/subject/day orally for 28 days to healthy volunteers with very good safety results on 03rd April 2019. News & Events: AAIC 2019 Keystone Symposium Neuro4D...